On Jan. 11, 2021, TheNew York Times posted an article about the virtues of fecal immunochemical testing relative to colonoscopy. The story, “A Colonoscopy Alternative Comes Home” [https://www.nytimes.com/ 2021/ 01/ 11/ health/ colonoscopy-health-home-testing.html] depicted colonoscopy as a comparatively risky procedure with few advantages over less invasive methods of testing for colorectal cancer. It also offered the speculation that financial factors— namely, greater reimbursement for endoscopy—was behind the general preference of gastroenterologists for colonoscopy over stool tests.
Trending
- Inside GI Mastermind: Why Many in GI Are Re-evaluating How They Prepare for the Future
- Amazon, Perplexity and OpenAI Compete to Own the First Click in Healthcare (PYMNTS)
- Optimizing Bowel Prep for Inpatient Colonoscopy (GI & Endoscopy News)
- The Rise of MAC in GI Procedures: Sleeping but Desaturating (GI & Endoscopy News)
- NYU Stern Report Urges Regulation of Private Equity in Healthcare (MedCity News)
- AI doctor startup Doctronic garners $40M (MobiHealthNews)
- The difference between selling to private equity, a hospital or a partner (Medical Economics)
- Liquid Biopsy Technology Detects Over 95% of Early-Stage Cancers in Blinded Validation Study (Clinical Lab Products)
